Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
about
Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data reviewAntiepileptic drug monotherapy for epilepsy: a network meta-analysisTreatment for epilepsy in pregnancy: neurodevelopmental outcomes in the childTreatment for epilepsy in pregnancy: neurodevelopmental outcomes in the childTreatment for epilepsy in pregnancy: congenital malformation outcomes in the childPreconception counselling for women with epilepsyPhenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizuresThe Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature ReviewGenetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)Management of epilepsy during pregnancy: an updateMedical management of epileptic seizures: challenges and solutionsMood stabilizers in pregnancy and lactationValproate in the treatment of epilepsy in girls and women of childbearing potentialDrugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risksA decision analysis of long-term lithium treatment and the risk of renal failurePharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringEpilepsy during pregnancy: focus on management strategiesCongenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort StudyImpact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.Understanding ictogenesis in generalized epilepsies."Late" Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn.Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomesTime to 12-month remission and treatment failure for generalised and unclassified epilepsy.MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.Carbamazepine clearance and seizure stability during pregnancy.Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study of 1.2 million singletons.Antiepileptic drugs in women with epilepsy during pregnancyThe prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugsIncreased homocysteine levels in valproate-treated patients with epilepsy: a meta-analysisFirst-degree relative risk: in utero levetiracetam and valproate exposure.Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort studyLamotrigine dosing for pregnant patients with bipolar disorder.Current position of phenobarbital in epilepsy and its future.Haemorrhagic strokes in pregnancy and puerperium.Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.Bicuspid aortic valve and severe aortic stenosis in a newborn exposed to carbamazapine during pregnancy.Teratogenic risk and contraceptive counselling in psychiatric practice: analysis of anticonvulsant therapy.IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study
P2860
Q24185852-483165B3-1B8E-4234-AE29-D1634B50BD36Q24187678-A766AE21-BA1F-4B31-88B2-88FAE241A4B1Q24193032-E83D3B87-D927-4510-A74B-6F58FF4182D2Q24197594-CE5867E2-88E9-48DE-B451-5E72D5C72028Q24197881-C511EA98-7186-46C9-8EFE-0483719EA075Q24198815-20D51B1F-3218-4245-A4D5-5D6D310DE912Q24200276-A6B7F52B-796F-4DBD-AFA2-DA162BF9FE87Q26741366-1E802798-DBD1-4363-9E53-D128FBC1B662Q26741618-9C65543D-54E0-4F10-8595-9C7386D534C2Q26752470-54FFE046-F859-46ED-B222-89AF4168E0AEQ26766413-557A0D73-E8F9-4347-BD92-9E95D8DCB8CFQ26795394-9EC86990-FA8E-4E38-98D6-3443CC11F0A7Q26865670-56229048-2886-4D25-A435-D23807F82D3EQ26991704-4D0C6AE0-22DA-4C16-BDF2-0138FBDB957BQ27004676-1E77751D-198F-49EB-9571-19F5DAAC5307Q27027293-93A3D993-B1EE-4992-B616-8CEAFE6B6141Q28080299-8F8E86A2-5FD1-4AE4-9665-C6E2A38F87F6Q28546202-ABDD1F3B-B56F-4EF7-8EB1-BCE1262EF5CEQ30443028-CECB4B00-A9EC-4A6B-9CE6-1547A5CDE059Q30540714-A845BC5A-6232-4517-BFB1-1E775C66ACB8Q30827533-B6BB8419-47FB-4C6A-99A2-10E3E27C43A6Q33588303-F343ED78-F983-4B93-806F-55C834B33957Q33640535-C15650D7-2D57-4BE7-8E24-769AF5AA405FQ33658630-CE0838A5-C6D1-40F3-B452-9D6CD40B9029Q33683865-035DA21F-37CD-4A74-B534-9D1D0D048B86Q33696210-6C10D4A7-540B-43DD-A6FA-D0D982A3BEE4Q33795191-EE23DB9C-3874-420A-8F6E-3C53FE4677C7Q33949402-45A92C11-4D13-43B3-9023-8872AAACC468Q33970119-94689692-DCC7-4623-8035-0F5647BD112FQ33995961-AD0FF989-E8D8-426F-97B7-1886709A95CAQ33996219-6C4392C1-35BF-4D79-B16B-836317EFC4B5Q34077289-D37D5573-CBAE-4139-8570-2D25CF315F91Q34131260-BB22E736-8E8E-4FED-BEFF-A36BA8D64698Q34315078-CF4A012C-6F13-4BDE-BD84-03F86329D53AQ34366117-4B8DC615-D1A9-4360-91A7-51812A67DC0CQ34544208-47F08F49-E9FB-4D86-930A-7A016EDE2C4CQ34823805-838A8E1A-8DBE-47EF-87AF-9EDE428E1430Q34843195-227E6086-90A4-44D0-B41B-47ED66FF9EB1Q34997710-68796438-0DF2-4596-8D1A-544907B3DE80Q35106308-1D5B7B06-7E9F-448B-A543-51FCA00A4882
P2860
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Dose-dependent risk of malform ...... ilepsy and pregnancy registry.
@ast
Dose-dependent risk of malform ...... ilepsy and pregnancy registry.
@en
type
label
Dose-dependent risk of malform ...... ilepsy and pregnancy registry.
@ast
Dose-dependent risk of malform ...... ilepsy and pregnancy registry.
@en
prefLabel
Dose-dependent risk of malform ...... ilepsy and pregnancy registry.
@ast
Dose-dependent risk of malform ...... ilepsy and pregnancy registry.
@en
P2093
P50
P1433
P1476
Dose-dependent risk of malform ...... ilepsy and pregnancy registry.
@en
P2093
Dina Battino
EURAP study group
Erminio Bonizzoni
Frank Vajda
John Craig
P304
P356
10.1016/S1474-4422(11)70107-7
P577
2011-06-05T00:00:00Z